These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19638151)

  • 1. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?
    Garratty G
    Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.
    Gaines AR; Lee-Stroka H; Byrne K; Scott DE; Uhl L; Lazarus E; Stroncek DF
    Transfusion; 2009 Jun; 49(6):1050-8. PubMed ID: 19220820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Golla S; Horkan C; Dogaru G; Teske TE; Christopher K
    Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular anti-D globulin injection for treatment of chronic idiopathic thrombocytopenic purpura.
    Dutta TK; Hamide A; Goel A; Kashyap R; Ramesh J
    J Assoc Physicians India; 2000 Mar; 48(3):365. PubMed ID: 11229136
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.
    Levendoglu-Tugal O; Jayabose S
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):460-3. PubMed ID: 11878583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).
    Tarantino MD; Bussel JB; Cines DB; McCrae KR; Gernsheimer T; Liebman HA; Wong WY; Kulkarni R; Grabowski E; McMillan R
    Blood; 2007 Jun; 109(12):5527; author reply 5528. PubMed ID: 17554071
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.
    Sandler SG
    Curr Opin Hematol; 2001 Nov; 8(6):417-20. PubMed ID: 11604585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia.
    Meyer O; Kiesewetter H; Hermsen M; Salama A
    Eur J Haematol; 2004 Jul; 73(1):71-2. PubMed ID: 15182342
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-D: mechanisms of action.
    Ware RE; Zimmerman SA
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):14-22. PubMed ID: 9523745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy.
    Kayyali HR; Abdelmoity AT; Morriss MC; Graf WD
    J Child Neurol; 2008 Mar; 23(3):325-30. PubMed ID: 18184936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes as therapy for autoimmunity.
    Clynes R
    J Clin Invest; 2005 Jan; 115(1):25-7. PubMed ID: 15630438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.